Guggenheim Downgrades Dermira to Neutral

Guggenheim analyst Seamus Fernandez downgrades Dermira (NASDAQ:DERM) from Buy to Neutral.

Benzinga · 02/03/2020 11:34

Guggenheim analyst Seamus Fernandez downgrades Dermira (NASDAQ:DERM) from Buy to Neutral.